## UNH: UnitedHealth Group Incorporated - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -1.2% below STRENGTH zone (3.0-6.0%); PEG 1.26 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($313.48)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. UnitedHealth: Undervalued Blue-Chip Stock With Multiple Levers To Pull & Ways To Win (UNH)**
- Source: Seeking Alpha | 20251229T143310 | Bullish | Relevance: 100%
- UnitedHealth (UNH) is a $297 billion healthcare behemoth providing health insurance, pharmacy benefit management, and care delivery. The company boasts significant cash reserves, a 16-year dividend growth streak with a 10-year CAGR of 19.3%, and an 18.5% CAGR in adjusted EPS over the same period. Despite current risks such as higher medical costs and DOJ investigations, the stock appears undervalued with P/E and sales multiples well below historical averages, and its dividend is considered highly secure.

**2. Live Oak Private Wealth LLC Has $10.94 Million Stock Holdings in UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251229T114203 | Somewhat-Bullish | Relevance: 100%
- Live Oak Private Wealth LLC reduced its stake in UnitedHealth Group Incorporated by 9.6% in the third quarter, now holding 31,688 shares valued at approximately $10.94 million. UnitedHealth Group (NYSE:UNH) constitutes 1.5% of the fund's holdings and is its 20th largest position. The stock currently has a "Hold" consensus rating from analysts, with an average price target of $385.54.

**3. Bretton Capital Management LLC Has $7.49 Million Stock Holdings in UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251229T095154 | Somewhat-Bullish | Relevance: 100%
- Bretton Capital Management LLC significantly increased its stake in UnitedHealth Group, holding 21,700 shares valued at $7.493 million, making it the sixth-largest holding in their portfolio. UnitedHealth Group reported strong Q3 earnings, beating analyst expectations with an EPS of $2.92 and revenue of $113.16 billion. The company also announced a quarterly dividend of $2.21, reflecting an annualized yield of 2.7%.

**4. UnitedHealth Group (UNH) Stock Today: Weekend Market Close, Fresh Headlines, Analyst Targets, and What to Watch Before Mondayâ€™s Open**
- Source: ts2.tech | 20251228T154258 | Neutral | Relevance: 100%
- UnitedHealth Group (UNH) ended the weekend near $332, with investors balancing recovery potential against execution and regulatory risks. Key headlines include Barron's highlighting the need to rebuild confidence after Medicare Advantage disruption and a Wall Street Journal investigation into insurer-owned pharmacy practices. Investors are keenly watching for the Jan. 27, 2026, earnings release and 2026 guidance, which is expected to be a major catalyst for the stock.

**5. PineStone Asset Management Inc. Decreases Stake in UnitedHealth Group Incorporated $UNH**
- Source: MarketBeat | 20251228T130911 | Neutral | Relevance: 100%
- PineStone Asset Management Inc. has reduced its Q3 stake in UnitedHealth Group by 6.6%, selling 54,732 shares, but UNH remains its 21st-largest holding valued at $267.5 million. UnitedHealth reported strong Q3 earnings, beating EPS estimates, with revenue up 12.2% year-over-year, and pays an annualized dividend of $8.84. While institutional ownership is high and includes a significant stake by Berkshire Hathaway, analyst consensus for UNH is currently a "Hold" with an average price target of $385.54.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 23 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.0% (-0.3%)
- Blackrock Inc.: 8.2% (-1.4%)
- State Street Corpora: 4.9% (-1.8%)
- JPMORGAN CHASE & CO: 4.1% (+85.6%)
- Geode Capital Manage: 2.4% (+2.2%)

### Key Risks

1. Long-term trend broken: trading 6.3% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.26 suggests fair value with growth premium. Forward P/E 18.5x stretched relative to 9% growth. Balance sheet: $5.1B free cash flow. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $298.0B |
| Beta | 0.43 |
| 52W Range | $234.60 - $606.36 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.26 |
| Forward P/E | 18.5 |
| Current P/E | 20.1 |
| YoY Growth | 8.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.7% to -1.2% (+1.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.2pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.7%) - potential reversal signal. Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 49. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.17% (CS: 29) | Neutral |
| RSI_14 | 48.7 | Neutral |
| MACD Histogram | -0.00 | Bearish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 0.984x | Below |
| vs SMA200 | 0.937x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $328.96
- **Stop Loss:** $313.48 (4.7% risk)
- **Target:** $344.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 89
- **Position Value:** $29,277.44
- **Portfolio %:** 29.28%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-01-15 (Est: $2.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.81 | $2.92 | +4.0% |
| 2025Q2 | $4.45 | $4.08 | -8.2% |
| 2025Q1 | $7.29 | $7.20 | -1.3% |
| 2024Q4 | $6.74 | $6.81 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*